Fed. Circ. Upholds P&G's Actonel Patent

Law360, New York (May 13, 2009, 12:00 AM EDT) -- A federal appeals court has ruled that generic-drug maker Teva Pharmaceutical Industries Ltd. infringed a valid patent on Procter & Gamble's osteoporosis drug Actonel when it filed an application to make a generic version of the drug.

Judge Marilyn L. Huff, sitting by designation on a three-judge panel of the U.S. Court of Appeals for the Federal Circuit, ruled Tuesday that a lower court was right to rule that U.S. Patent Number 5,538,122 is valid.

The decision resolves Teva's appeals of three separate patent suits filed...
To view the full article, register now.